FDA NDC Directory · JSON-LD · Markdown

Humalog Tempo Pen

NDC 0002-8213 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameInsulin lispro
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA020563
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN LISPRO (100 [iU]/mL)
Marketing started20170606
Marketing ended20270404
Package count1

External sources

Source: openFDA. Public-domain (CC0).